Leukaemia Warning Symptoms: Only 14% of Brits know the warning signs of leukaemia as thousands are diagnosed in A&E every year. Leukaemia charities highlight the urgent need to raise awareness of signs and symptoms to stop the deadly blood cancer devastating lives. New research has revealed that a mere 14% of UK adults know the […]
Read More… from Low Awareness of Leukaemia Symptoms Puts Lives at Risk
Rare diseases affect fewer than 1 in 2,000 people individually. However, with over 7,000 different types identified, their global impact is significant. In the Asia-Pacific region, approximately 258 million people have a rare disease, the highest number globally, with over 45 million in Southeast Asia alone. This vast number highlights significant challenges in treatment, as […]
Read More… from AI platform demonstrates promising results in treating patient with rare cancer
Leukaemia UK has today announced that it will channel £600,000 into four new research projects, each aimed at finding kinder, more effective treatments for acute myeloid leukaemia (AML); a form of blood cancer which has one of the worst survival rates of any cancer. Acute myeloid leukaemia (AML) affects almost 3,100 people in the UK […]
Read More… from Pioneering projects into one of the deadliest forms of cancer
A drug being developed to combat metabolic diseases such as type 2 diabetes and Alzheimer’s disease may offer new treatment hope for people with chronic myeloid leukaemia (CML), a form of blood cancer. The new study, led by the University of Glasgow and published in Nature Communications, focused on understanding the unique role glucose plays […]
Read More… from New treatment hope for chronic myeloid leukaemia
On World Cancer Day 2022 – ‘Turning Time‘ : A Richmond man has written about his experience ‘cheating cancer’ in a book he’s selling to raise funds for blood cancer charity Anthony Nolan. Richard Jefferies, 53, was diagnosed with myelodysplastic syndrome (MDS) a type of rare blood cancer ten years ago. A keen runner, he […]
New blood cancer gene defect can be treated with existing drugs: A defective gene, normally found in blood cancers, could be treated with drugs already available for cancers with similar gene defects, scientists at Queen’s University Belfast and the University of Birmingham have revealed. The research team, funded mainly by Cancer Research UK and the […]
Read More… from New blood cancer gene defect can be treated with existing drugs
IMPACT, the UK’s first ever clinical trials partnership dedicated to improving the outcomes for blood cancer and stem cell transplant patients, has appointed Professor Ronjon Chakraverty as Medical Director. Ronjon Chakraverty is currently Professor of Haematology at the University of Oxford. He previously led the merger of the Royal Free and University College London Hospital Haematology […]
Read More… from IMPACT appoints Professor Ronjon Chakraverty as Medical Director
A new study will look at how patients, who receive stem cell transplants for blood cancers and blood disorders, react to COVID-19 infection during their recovery. Announced by IMPACT, a partnership of organisations committed to improving the survival rates of stem cell transplant patients by increasing the number of clinical trials across the UK, the […]
Read More… from Covid-19 impact on blood cancer patients receiving stem cell transplants
A new study suggests that after genetic matching, the age of a stem cell donor is the most important characteristic influencing patient survival following a stem cell transplant. Previous studies have suggested that donor characteristics including sex, ethnicity, blood type and previous pregnancies could all affect patient survival, making it difficult for transplant clinicians to […]
What is cancer? How is it caused? Can it be prevented? […]